Fig. 3: Kaplan–Meier cumulative survival curve for all-cause workforce exit among workforce active persons newly diagnosed with Parkinson’s disease and controls by age at diagnosis/matching.
From: Time to workforce exit after a Parkinson’s disease diagnosis
Survival distributions differed significantly between PD cases and controls for each age group (log-rank tests, all P < 0.001). a The median survival was 147.0 (95% CI: 133.4–160.6) months in PD patients diagnosed <50 years old (events: 188, censored: 324), but could not be estimated in controls <50 years (events: 142, censored: 1896). b The median workforce survival was 68.0 (95% CI: 65.1–70.9) months in PD patients 50–59 years (events: 970, censored: 374) and 90.0 (95% CI: 88.4–91.6) months in controls (events: 3171, censored: 2185). c The median workforce survival was 19.0 (95% CI: 17.9–20.1) months in PD patients ≥60 years (events: 1183, censored: 35) and 26.0 (95% CI: 25.1–26.9) months in controls (events: 4675, censored: 214). PD Parkinson’s disease, CI confidence interval.
